Other
FSFI
FSFI is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completed
Reduction Nymphoplasty: Assessment of the Impact on Sexuality, Self-Esteem and Screening for Dysmorphophobia
NCT05900869
completednot_applicable
Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions
NCT04816370
completed
The Human Papilloma Virus Effect on Sexual Life
NCT03837028
Clinical Trials (3)
Showing 3 of 3 trials
NCT05900869
Reduction Nymphoplasty: Assessment of the Impact on Sexuality, Self-Esteem and Screening for Dysmorphophobia
NCT04816370Not Applicable
Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions
NCT03837028
The Human Papilloma Virus Effect on Sexual Life
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3